Company intelligence / Profile preview

Range Impact

Cleveland, Ohio, United States

Ownership: Public · RNGE
Development stage: Other

Overview

As of September 2024, Range Impact completed the sale of all cannabinoid drug development assets (Graphium Biosciences) to Placer Biosciences. The assets included early-stage cannabinoid-based therapeutics designed to avoid psychoactive effects. Range Impact now focuses on environmental and social solutions for economically disadvantaged regions, especially Appalachia.

Industry: Investors

Financials

Market cap: $95.7M
Total revenue: $1.1M
Enterprise value: $96.6M

Beyond the preview

Go deeper on Range Impact.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Range Impact.

Explore the full profile